RTW Biotech Opportunities Ltd USD (RTW.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 840.66M |
| Enterprise Value | 995.23M |
| P/E Ratio | 1.83 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 4.11 |
| Price/Book Ratio | 0.81 |
| Enterprise/Revenue | 5.24 |
| Enterprise/EBITDA | 2.4 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 2.5 |
| Operating Margin | 2.54 |
AD
Management Effectiveness
| Return On Assets | 0.35 |
| Return On Equity | 0.53 |
Income Statement
| Revenue | 258.01M |
| Revenue/Share | 0.57 |
| Gross Profit | 250.89M |
| EBITDA | 245.19M |
| Net Income | 245.19M |
| Diluted EPS | 0.63 |
Balance Sheet
| Total Cash | 3.65M |
| Total Cash/Share | 0.01 |
| Total Debt | 210.21M |
| Total Debt/Equity | 0.23 |
| Current Ratio | 0.26 |
| Book Value Per Share | 3.14 |
Price History
| 52-Week Change | 42.94 |
| 52-Week High | 2.64 |
| 52-Week Low | 1.63 |
| Moving Average 50 Days | 2.4 |
| Moving Average 200 Days | 2.25 |
Statistics
| Average Volume | 339,325 |
| Shares Outstanding | 321.14M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.03 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
